8 Results

People

  1. Drilon
    Drilon
  2. Gomez
    Gomez
  3. Arcila
    Arcila
  4. Flynn
    Flynn
  5. Kris
    Kris
  6. Lebow
    Lebow
  7. Liu
    Liu
  8. Li
    Li
  9. Murciano-Goroff
    Murciano-Goroff
  10. Offin
    Offin

Groups

  1. Biostatistics Service (8)
  2. Department of Medicine (8)
  3. Epidemiology and Biostatistics (8)
  4. Solid Tumor Oncology Division (8)
  5. Thoracic Oncology (8)
  6. GSK Faculty (5)
  7. Graduate Medical Education (5)
  8. Radiology, Department of (5)
  9. Body Imaging Service (4)
  10. GME, Radiation Oncology (4)
  1. "Alexander Drilon"
  2. "Thoracic Oncology"
  3. "2022"
  4. "Biostatistics Service"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
Groups
  1. Biostatistics Service (8)
  2. Department of Medicine (8)
  3. Epidemiology and Biostatistics (8)
  4. Solid Tumor Oncology Division (8)
  5. Thoracic Oncology (8)
  6. GSK Faculty (5)

More Groups

People
  1. Alexander Drilon (8)
  2. Andreas Rimner (4)
  3. Daniel Gomez (4)
  4. Jessica Flynn (4)
  5. Bob Li (3)
  6. Charles Rudin (3)

More People

Years
  1. 2022 (8)
Publications
  1. Journal of Clinical Oncology (2)
  2. British Journal of Cancer (1)
  3. Clinical Cancer Research (1)
  4. International Journal of Radiation Oncology, Biology, Physics (1)
  5. JCO Precision Oncology (1)
  6. Nature Medicine (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (3)
  2. Nature Publishing Group (2)
  3. American Association for Cancer Research (1)
  4. Elsevier Inc. (1)
  5. Oxford University Press (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Journal Article

    Hubbeling, H.; Choudhury, N.; Flynn, J.; Zhang, Z. G.; Falcon, C.; Rusch, V. W.; Park, B. J.; Ziv, E.; Shaverdian, N.; Gelblum, D. Y.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Genomic alterations in ALK fusion-positive non-small cell lung cancer (NSCLC) patients with brain metastases
    Meeting Abstract

    Eichholz, J.; Miao, E.; Lebow, E.; Walch, H.; Flynn, J.; Zhang, Z.; Hubbeling, H.; Beal, K.; Moss, N.; Yu, K.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Central nervous system (CNS) outcomes and progression patterns in patients with RET fusion-positive lung cancers treated with selpercatinib
    Meeting Abstract

    Murciano-Goroff, Y. R.; Falcon, C. J.; Lin, S. T.; Dhawan, A.; Grimaldi, G.; Liu, D.; Wilhelm, C.; Thomas, R.; Iasonos, A.; Drilon, A. E.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers
    Meeting Abstract

    DeMatteo, R.; Goldman, D. A.; Lin, S. T.; Buonocore, D. J.; Gao, J.; Chang, J. C.; Rekhtman, N.; Offin, M.; Yu, H. A.; Isbell, J. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Bioinformatically expanded next-generation sequencing analysis optimizes identification of therapeutically relevant MET copy number alterations in >50,000 tumors
    Journal Article

    Solomon, J. P.; Yang, S. R.; Choudhury, N. J.; Ptashkin, R. N.; Eslamdoost, N.; Falcon, C. J.; Martin, A.; Plodkowski, A.; Wilhelm, C.; Shen, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • CNS outcomes in ALK fusion positive NSCLC patients with BM who received alectinib with or without local therapy
    Meeting Abstract

    Miao, E.; Lebow, E. S.; Eichholz, J.; Flynn, J.; Zhang, Z.; Hubbeling, H. G.; Beal, K.; Moss, N. S.; Yu, K.; Yang, J. T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save